ASCO GI Conference Coverage
Filter News By:
Featured News
View all
More News
(Medscape Medical News) Feb 18, 2020 - Should the age be lowered in view of the mounting reports of an increase in CRC in younger adults? Experts argued both for and against the move here at the 2020 Gastrointestinal Cancers Symposium.
(Medscape Medical News) Jan 27, 2020 - For patients with unresectable hepatocellular carcinoma (HCC), the combination of atezolizumab (Tecentriq, Genentech) plus bevacizumab (Avastin, Genentech) has already shown better efficacy than...
(MedPage Today) Jan 25, 2020 - Only the two-drug combination of encorafenib (Braftovi) plus cetuximab (Erbitux) will undergo regulatory review by the FDA for metastatic BRAF-mutant colorectal cancer at this time, a researcher reported...
(MedPage Today) Jan 24, 2020 - So-called switch maintenance with an immune checkpoint inhibitor failed to improve overall survival (OS) in treatment-naive HER2-negative advanced gastric or gastroesophageal junction cancer, results of a...
(MedPage Today) Jan 26, 2020 - Resection of the primary tumor ahead of chemotherapy yielded no survival benefit for newly diagnosed metastatic colorectal cancer (CRC) patients with asymptomatic primaries, a randomized trial from Japan...
(Medscape Medical News) Jan 24, 2020 - Escalating the dose of radiation therapy does not appear to improve outcomes for patients with esophageal cancer who are receiving definitive chemoradiation, according to new findings.
(Taiho Oncology) Jan 25, 2020 - Taiho Oncology, Inc. announced today the presentation of a pooled analysis for hematologic adverse events of the global Phase III TAGS and RECOURSE trials evaluating LONSURF® (trifluridine and tipiracil) in...
(Yahoo! News) Jan 27, 2020 - All patients showed tumor regression by radiographic scan at 8 weeks and confirmation by further tumor shrinkage at 16 weeks; clinical benefit achieved in 100% (n=5) of patients.
(Yahoo! Finance) Jan 25, 2020 - NantHealth, Inc. today announced results of a fifty-gene breast cancer RNA subtype classifier applied to 167 colorectal cancer (CRC) patients during a poster session at the 2020 GI.
(Yahoo! Finance) Jan 27, 2020 - AVEO Oncology and Biodesix, Inc. today announced the presentation of results from an investigator-sponsored Phase 1b trial of ficlatuzumab, AVEO’s potent hepatocyte growth factor (HGF) inhibitory antibody...
Expert Videos

OBR Tweets

Sep 24
Cristina Suárez, MD, of @vallhebron offers opinion on whether the CheckMate 9ER trial is practice-changing #ESMO20 https://t.co/6m8UCjJPxE

Sep 24
Andrew Schmidt, MD, @dr_aschmidt of @DanaFarber regarding the COVID-19 and Cancer Outcomes Study (CCOS) presented a… https://t.co/tbmT0twPFA

Sep 24
Erika Hamilton, MD, @ErikaHamilton9 of @SarahCannonDocs regarding the Phase III monarchE trial presented at #ESMO20 https://t.co/AiqtvpEZ7u

Sep 24
Giuseppe Giaccone, PhD, MD, of @WeillCornell regarding the step 1 results of the Phase III ATALANTE-1 trial in NSCL… https://t.co/D5Su3qEkbb

Sep 24
Pasi A. Jänne, MD, PhD, of @DanaFarber shares data from #ESMO20 investigating mobocertinib https://t.co/idTloLVyBj

Sep 24
Maha Hussain, MD, of @LurieCancer provides perspective on the Phase III PROfound study presented at #ESMO20 https://t.co/NerWJUf67S

Aug 25
At the ASCO20 Virtual Education Program, Nilanjan Ghosh, MD, PhD, a hematologist-oncologist at the @LevineCancer, p… https://t.co/o2s69MGfrW

Aug 25
At the #ASCO20 Virtual Education Program, Jaleh Fallah @Jaleh_Fallah, MD, a Hematology/Oncology Fellow at the Cleve… https://t.co/QDkyebDuvp

Aug 25
The financial toxicity that patients and oncology practices are potentially exposed to due to the high costs associ… https://t.co/QA8A13PAGT

Aug 25
At separate #AACR and #COA virtual meetings held in July, participants discussed the challenges of providing cancer… https://t.co/8fs8SKl65a